Latest from covishield
The Covid-19 vaccination experience has opened a plethora of possibilities for adult vaccination
The Bombay High Court has restrained two social media influencers from posting defamatory content about Serum Institute of India, its CEO and their Covishield product in an interim application filed by SII in a defamation suit against the influencers. The court directed Yohan Tengra and Ambar Kori to remove the content from Twitter and YouTube. The SII claims the content posted by the duo about multiple deaths being due to the side effects of the vaccine was not only targeted at SII but also its CEO, and sought directions to Twitter and YouTube to take down defamatory content.
Mumbai's rollout of the intranasal Covid-19 vaccine saw a low response on the first day with only 23 senior citizens taking the booster dose. The vaccine, iNCOVACC by Bharat Biotech, will be administered to those above the age of 60 and eligible six months after their second dose of either Covishield or Covaxin. The state health department recently procured 2 lakh doses, of which BMC procured around 2,000 doses. The vaccine will be given through spot registration at 24 centres across Mumbai.
PMC health officials since April 1 ran out of vaccine stock and were waiting for the vaccine supply. The civic body this week received 512 doses of the nasal vaccine iNCOVACC
Updated on Apr 28, 2023 11:51 PM IST